Parker v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided October 22, 2019·No. 17-917·Unpublished

Opinion

In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 17-917V

************************* * * RICHARD K. PARKER, * * UNPUBLISHED * Petitioner, * * Special Master Katherine E. Oler v. * * * Filed: June 19, 2019 SECRETARY OF HEALTH AND * HUMAN SERVICES, * Interim Attorneys’ Fees and Costs * * Respondent. * * ************************* *

Ramon Rodriguez, III, Sands Anderson PC, Richmond, VA, for Petitioner. Sarah C. Duncan, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION AWARDING INTERIM ATTORNEYS’ FEES AND COSTS1

On July 7, 2017, Richard K. Parker (“Petitioner”) filed a petition for compensation with the National Vaccine Injury Compensation Program,2 alleging that he suffered Parsonage-Turner syndrome (“PTS”) as a result of a pneumococcal 13-valent conjugate (Prevnar-13) vaccination he received on November 21, 2014. Pet., ECF No. 1 at 1.

On May 1, 2019, Petitioner filed an application for interim attorneys’ fees and costs requesting a total of $8,939.85 for work performed from January 27, 2016 through July 12, 2017. See Fees App., ECF No. 36.

1 Because this unpublished decision contains a reasoned explanation for the action in this case, I intend to post this decision on the United States Court of Federal Claims’ website, in accordance with the E- Government Act of 2002, Pub. L. No. 107-347, § 205, 116 Stat. 2899, 2913 (codified as amended at 44 U.S.C. § 3501 note (2012)). This means the ruling will be available to anyone with access to the internet. As provided by 42 U.S.C. § 300aa-12(d)(4)(B), however, the parties may object to the decision’s inclusion of certain kinds of confidential information. Specifically, under Vaccine Rule 18(b), each party has fourteen days within which to request redaction “of any information furnished by that party: (1) that is a trade secret or commercial or financial in substance and is privileged or confidential; or (2) that includes medical files or similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” Vaccine Rule 18(b). Otherwise, the Decision in its present form will be available. Id. 2 The Vaccine Program comprises Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3758, codified as amended at 42 U.S.C. §§ 300aa-10 through 34 (2012) (“Vaccine Act” or “the Act”). Individual section references hereafter will be to § 300aa of the Act (but will omit that statutory prefix). Respondent filed a response to Petitioner’s application on May 13, 2019. Fees Resp., ECF No. 38. Respondent argues that “[n]either the Vaccine Act nor Vaccine Rule 13 requires [R]espondent to file a response to a request by a petitioner for an award of attorneys’ fees and costs.” Id. at 1. Respondent adds that he “defers to [me] to determine whether or not petitioner has met the legal standard for an award of interim fees and costs” in this case. Id. at 2. Respondent does state that he “is satisfied the statutory requirements for an award of attorneys’ fees and costs are met in this case.” Id. (citing 42 U.S.C. § 300aa-15(e)(1)(A)-(B)). Additionally, Respondent “requests that [I] exercise [my] discretion and determine a reasonable award for attorney’s fees and costs.” Id. at 3. Respondent has not raised any issue with respect to reasonable basis. See generally Fees Resp.

For the reasons discussed below, I hereby GRANT IN PART Petitioner’s application, awarding a total of $8,254.65 in interim attorneys’ fees and costs.

I. Legal Standard for Interim Attorneys’ Fees and Costs The Federal Circuit has held that an award of interim attorneys’ fees and costs is permissible under the Vaccine Act. Shaw v. Sec’y of Health & Human Servs., 609 F.3d 1372 (Fed. Cir. 2010); Avera v. Sec’y of Health & Human Servs., 515 F.3d 1343 (Fed. Cir. 2008). In Cloer, the Federal Circuit noted that “Congress made clear that denying interim attorneys' fees under the Vaccine Act is contrary to an underlying purpose of the Vaccine Act.” Cloer v. Sec’y of Health & Human Servs., 675 F.3d 1358, 1361-62 (Fed. Cir. 2012).

In Avera, the Federal Circuit stated, “[i]nterim fees are particularly appropriate in cases where proceedings are protracted, and costly experts must be retained.” Avera, 515 F.3d at 1352. Likewise, in Shaw, the Federal Circuit held that “where the claimant establishes that the cost of litigation has imposed an undue hardship and there exists a good faith basis for the claim, it is proper for the special master to award interim attorneys' fees.” 609 F.3d at 1375. Avera did not, however, define when interim fees are appropriate; rather, it has been interpreted to allow special masters discretion. See Avera, 515 F.3d; Kirk v. Sec’y of Health & Human Servs., No. 08-241V, 2009 WL 775396, at *2 (Fed. Cl. Spec. Mstr. Mar. 13, 2009); Bear v. Sec’y of Health & Human Servs., No. 11-362V, 2013 WL 691963, at *4 (Fed. Cl. Spec. Mstr. Feb. 4, 2013). Even though it has been argued that a petitioner must meet the three Avera criteria -- protracted proceedings, costly expert testimony, and undue hardship -- special masters have instead treated these criteria as possible factors in a flexible balancing test. Avera, 515 F.3d at 1352; see Al-Uffi v. Sec’y of Health & Human Servs., No. 13-956V, 2015 WL 6181669, at *7 (Fed. Cl. Spec. Mstr. Sept. 30, 2015).

The undue hardship inquiry looks at more than just financial involvement of a petitioner; it also looks at any money expended by a petitioner’s counsel. Kirk, 2009 WL 775396, at *2 Referring to Avera, Chief Special Master Golkiewicz in Kirk found that “the general principle underlying an award of interim fees was clear: avoid working a substantial financial hardship on petitioners and their counsel.” Id. II. Discussion A petitioner is eligible for an interim award of reasonable attorneys’ fees and costs if the special master finds that a petitioner has brought his petition in good faith and with a reasonable basis. §15(e)(1); Avera, 515 F.3d at 1352; Shaw, 609 F.3d at 1372; Woods v. Sec’y of Health & Human Servs, 105 Fed. Cl. 148 (2012), at 154; Friedman v. Sec’y of Health & Human Servs., 94 Fed. Cl. 323, 334 (2010); Doe 21 v. Sec’y of Health & Human Servs., 89 Fed. Cl. 661, 668 (2009); Bear, 2013 WL 691963, at *5; Lumsden v. Sec’y of Health & Human Servs., No. 97-588V, 2012 WL 1450520, at *4 (Fed. Cl. Spec. Mstr. Mar. 28, 2012). Respondent did not raise any objection to the good faith or reasonable basis for this claim. See Fees Resp. I find the petition was filed in good faith and with a reasonable basis. As there is no other reason to deny the award of interim attorneys’ fees and costs, I will award Petitioner’s reasonable fees and costs in this instance.

Petitioner requests a total of $8,939.85 in attorneys’ fees and costs incurred while Petitioner’s counsel was with the Rawls Law Group. See Fees App. At this point, this claim has been pending for nearly two years. Further, Petitioner’s counsel transitioned to his new law firm, Sands Anderson, a few weeks after the complaint was filed and has indicated that he does not intend to seek additional attorneys’ fees and costs until the conclusion of this case. Id. at ¶3.

Free access — add to your briefcase to read the full text and ask questions with AI

Parker v. Secretary of Health and Human Services, (uscfc 2019).

Parker v. Secretary of Health and Human Services (Parker v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related